w w w . e l s e v i e r . c o m / l o c a t e / b j i d
The
Brazilian
Journal
of
INFECTIOUS
DISEASES
Brief
communication
Complete
substitution
of
the
Brazilian
endemic
clone
by
other
methicillin-resistant
Staphylococcus
aureus
lineages
in
two
public
hospitals
in
Rio
de
Janeiro,
Brazil
Raiane
Cardoso
Chamon
a,1,
Sthefanie
da
Silva
Ribeiro
a,1,
Thaina
Miranda
da
Costa
a,
Simone
Aranha
Nouér
b,
Katia
Regina
Netto
dos
Santos
a,∗aUniversidadeFederaldoRiodeJaneiro,InstitutodeMicrobiologiaPaulodeGóes,DepartamentodeMicrobiologiaMédica,RiodeJaneiro,
RJ,Brazil
bUniversidadeFederaldoRiodeJaneiro,FaculdadedeMedicina,HospitalUniversitárioClementinoFragaFilho,RiodeJaneiro,RJ,Brazil
a
r
t
i
c
l
e
i
n
f
o
Articlehistory:Received21July2016
Accepted28September2016
Availableonline19November2016
Keywords: Staphylococcusaureus Bloodstreaminfections USA100 Mupirocinresistance
a
b
s
t
r
a
c
t
Staphylococcusaureusisanimportantcauseofbloodstreaminfections.Therefore,themain
purposeofthisworkwastocharacterizeacollectionof139S.aureusisolatesfrom
blood-stream infectionsintwopublichospitalsinrelationtotheirantimicrobialsusceptibility
profile, staphylococcal cassettechromosomemectypes,and clonal relationship.
Methi-cillinresistanceandresistancetoother12agentswereaccessedbythediskdiffusiontest.
Minimuminhibitoryconcentrationtomupirocinwasalsodetermined.TheSCCmectypes
wereaccessedbymultiplexPCR,andtheclonalrelationshipwasdeterminedbypulsed
field gel electrophoresis method and restriction modification system characterization.
Besides,multilocussequencetypingwasperformedforrepresentativemethicillin-resistant
S. aureusisolates.ThemilitaryhospitalshowedadisseminationoftheNewYork/Japan
(USA100/ST5/CC5/SCCmecII)lineageassociatedtomultidrugresistance,includingmupirocin
resistance,andtheteaching hospitalpresentedpolyclonalandnon-multidrug resistant
MRSAisolates.CompletesubstitutionoftheBrazilianendemicclonebyotherlineageswas
foundinbothhospitals.Thesefindingscanhighlightdifferencesinpolicycontroland
pre-ventionofinfectionsusedinthehospitalsandachangeintheepidemiologicalprofileof
MRSAinBrazilianhospitals,withthereplacementofBEC,a previouslywell-established
clone,byotherlineages.
©2016SociedadeBrasileiradeInfectologia.PublishedbyElsevierEditoraLtda.Thisisan
openaccessarticleundertheCCBY-NC-NDlicense(http://creativecommons.org/licenses/
by-nc-nd/4.0/).
∗ Correspondingauthor.
E-mailaddress:santoskrn@micro.ufrj.br(K.R.dosSantos).
1 Theauthorscontributedequallytothiswork.
http://dx.doi.org/10.1016/j.bjid.2016.09.015
1413-8670/©2016SociedadeBrasileiradeInfectologia.PublishedbyElsevierEditoraLtda.ThisisanopenaccessarticleundertheCC
Staphylococcus aureus is considered an important cause
of bloodstream infections (BSI), which is associated
with high rates of mortality and morbidity.1 Analysis of
molecularcharacteristicsofS.aureusisolateshaveindicated
avariety ofcirculating lineages insidehospitals,according
tothegeographicarea.InUnitedStates,theNewYork/Japan
clone(USA100/ST5/CC5/SCCmecII)hasbeen replacedbythe
community-acquired MRSA (USA300/ST8/CC8/SCCmecIV)
lineage.1 In China, two pandemic hospital-acquired MRSA
(HA-MRSA) clonesare disseminated,theBrazilian endemic
clone(BEC/ST239/CC8/SCCmecIII)andtheUSA100.2InBrazil,
theBEClineageremainedprevalentinsidehospitals,3butan
increasingpresenceoftheclonesUSA400(ST1/CC1/SCCmecIV)
and the Pediatric clone (USA800/ST5/CC5/SCCmecIV) have
beenreportedinthelastdecade.3,4 Morerecently,SCCmecII
carrying isolates associated to the CC5 were detected
replacing, almost completely the BEC lineage among BSI
isolatesatahospitallocatedinSãoPaulocity.5
TheimplementationofaHealthCareAssociated
Preven-tionandControlCommittee(HAIPCC)ismandatorybylawin
Brazilianhospitalssince1997.6Thesemeasuresapplytothe
wholehealthcaresystem,suchasthepublicandtheprivate
sector.Publichospitalsareresponsibleforthecareofabout
75%oftheBrazilianpopulation,estimatedin192millionsof
habitants(2012data).However,fundingfortheUnifiedHealth
System(SistemaÚnicodeSaúde–SUS)hasnotbeensufficient
toensureadequatefinancialresourcesforthepublichealth
system,leadingtoinappropriatecontrolofdisseminationof
endemicresistantmicroorganisms.6Theaimofthepresent
studywastocharacterizeS.aureusisolatesfromBSIattwo
publichospitalsastheirantimicrobialresistanceandclonal
disseminationassociatedwithclinicalaspects.
Weevaluated139S.aureusconsecutiveisolatesfromBSI
recoveredina532-bedmilitaryhospital(Hospital1)andina
490-beduniversityteachinghospital(Hospital2),bothlocated
inRiodeJaneirocity,betweenJanuary2008andJune2009.This
studywasapprovedbytheResearchEthicsCommitteeunder
No.159/07.ClinicaldatafrompatientswithS.aureusBSIwere
retrospectivelyabstractedfromthehospitalrecords.S.aureus
isolateswereidentifiedbystandardmethods.BSIswere
clas-sifiedashospital-acquired(HA)orcommunity-acquired(CA)
accordingtotheCentersforDiseaseControl(CDC)criteria.
In order to characterize methicillin resistance,cefoxitin
disk diffusion test was used according to CLSI.7 Isolates
identifiedasMRSAwerealsosubmittedtoantimicrobial
sus-ceptibilitytestfor12 agentsbythediskdiffusionmethod.7
Minimum inhibitory concentration(MIC) tomupirocin was
determined by Etest® (AB-Biodisk, Solna, Sweden). The
SCCmec types were assessed by multiplex-PCR for MRSA
isolates.8Clonalrelationshipwasdeterminedbypulsed-field
gel electrophoresis(PFGE).9 Restrictionmodification system
characterization(RMtest)10 wasusedtoidentifytheclonal
complexes (CC) of methicillin susceptible S. aureus(MSSA)
isolates.Besides,multilocussequencetyping(MLST)was
per-formedforrepresentativeMRSAisolates.11TheFisher’sexact
test and chi-square testwere used tocompare categorical
data.Significancelevelwasestablishedat5%(p<0.05).
The distribution ofthe 139 S. aureus isolates and their
SCCmectypesandclonalcomplexesineachhospitalisshown
inTable1.Outof75isolatesofHospital1(H1),32(43%)were
characterizedasMRSA,whereasinHospital2(H2)from64
iso-lates13(20%)wereMRSAisolates(p=0.006).WhileatH1the
majorityofMRSAisolatescarriedtheSCCmectypeII(69%),at
H2theSCCmectypeIV(69%)wasthemostprevalent.Overall,
onlyoneisolatefromH2carriedtheSCCmectypeIIIandwas
assignedasST889/CC5.InrelationtotheCCassignment,the
majorityofMRSAandMSSAisolates(83%;62/75)atH1were
relatedtoCC1andCC5.However,therewasapolyclonal
dis-tributionofS.aureusisolatescausingBSI(CCs1,5,8,30,45,
221)atH2regardlessoftheirmethicillinresistance.
Characteristicsof45 MRSAisolatesfromBSIofpatients
from the twohospitalsevaluated are presentedinTable2.
Overall,93%(42isolates),75%(34),and35%(16)oftheMRSA
isolates were resistant to ciprofloxacin, clindamycin, and
mupirocin,respectively.AmongtheMRSAisolatesfromH1,
resistancetothreeormoredrugclasses(multidrugresistance
Table1–Distributionof139methicillin-susceptibleand-resistantStaphylococcusaureusisolates,SCCmectypesand clonalcomplexesfrombloodstreaminfections.
Hospital/methicillin-resistance (numberofisolates)
N(%)ofisolates
SCCmectype Clonalcomplexes
II III IV 1 5 8 30 45 221 ND Hospital1 MRSA(32) 22(69) 0 10(31) 9(28) 23(72) 0 0 0 0 0 MSSA(43) – – – 14(32) 16(37) 1(3) 2(5) 4(9) 0 6(14) Total(75) 23(31) 39(52) 1(1) 2(3) 4(5) 0 6(8) Hospital2 MRSA(13) 2(23) 1a(8) 9(69) 3(23) 7(53) 0 1(8) 1(8) 1(8) 0 MSSA(51) – – – 17(33) 6(12) 7(14) 7(14) 4(8) 0 10(19) Total(64) 20(31) 13(20) 7(11) 8(12.5) 5(8) 1(2) 10(15.5) MRSA,methicillin-resistantS.aureus;MSSA,methicillin-susceptibleS.aureus;SCCmec,Staphylococcalcassettechromosomemec;ND,not deter-mined;N,number.
Table2–Generalcharacteristicsof45methicillin-resistantStaphylococcusaureusisolatesfrombloodstreaminfections. Hospital/genotype (noofisolates) Isolate number Isolationdate (mm/dd/yy) Unitor floor Acquisition mode SCCmec type PFGE subtype Clonality ST/CC Antimicrobial resistance profile Hospital1(32)
A(22) 1223a 01/10/2008 11 HA II A1 USA100 5/5 cipclierymuptec 1224a 01/12/2008 ICU HA II A1 USA100 5/5 cipclierymup 1255a 09/02/2008 ICU HA II A1 USA100 5/5 cipclierymup 1258a 09/16/2008 ICU HA II A1 USA100 5/5 cipclierymup 1265a 09/23/2008 9 HA II A1 USA100 5/5 cipclierymup 1266a 09/24/2008 9 HA II A1 USA100 5/5 cipclierymup 1276a 02/12/2008 9 HA II A1 USA100 5/5 cipclierymup 1288a 03/12/2009 ICU HA II A1 USA100 5/5 cipclierymup 1289a 03/13/2009 11 HA II A1 USA100 5/5 cipclierymup 1309a 03/14/2009 ND HA II A1 USA100 5/5 cipclierymupclorif 1290a 03/19/2009 11 HA II A1 USA100 5/5 cipclicloery 1291a 03/31/2009 9 HA II A1 USA100 5/5 cipclierymup 1305a 06/04/2009 11 HA II A1 USA100 5/5 cipclierymupclorif 1308a 06/15/2009 10 HA II A1 USA100 5/5 cipclierymupclorif 1260a 09/17/2008 10 HA II A2 USA100 5/5 cipcliery
1263a 09/22/2008 11 HA II A2 USA100 5/5 cipcliery 1275a 12/02/2008 ICU HA II A2 USA100 5/5 cipcliery 1238a 05/26/2008 8 HA II A3 USA100 5/5 cipclierymup 1240a 05/27/2008 Em HA II A3 USA100 5/5 cipclierymup 1284a 02/02/2009 Em HA II A4 USA100 5/5 cipcliery 1285a 02/16/2009 11 HA II A4 USA100 5/5 cipcliery 1301a 05/27/2009 IU HA II A5 USA100 5/5 cipclicloery
B(9) 1229a 02/09/2008 11 HA IV B1 USA400 1/1 cipcliery
1237a 05/20/2008 11 HA IV B1 USA400 1/1 cipcliery
1307a 06/12/2009 ICU HA IV B1 USA400 1/1 cipclo
1231a 02/13/2008 11 HA IV B2 USA400 1/1 cip
1282a 01/22/2009 ICU HA IV B2 USA400 1/1 cipclo
1268a 09/26/2008 10 HA IV B3 USA400 1/1 cipclierygen
1283a 01/22/2009 ICU HA IV B3 USA400 1/1 cipclo
1295a 05/25/2009 9 HA IV B4 USA400 1/1 –
1302a 05/21/2009 ICU HA IV B5 USA400 1/1 cipclo
F(1) 1306a 06/04/2009 10 HA II F ND 105/5 cipclicloery
Hospital2(13)
A(1) 1087a 01/20/2008 11 HA II A1 USA100 5/5 cipclierymup
B(3) 1094a 01/16/2008 9 CA IV B1 USA400 1/1 cipcliery
1187a 06/12/2008 8 HA IV B1 USA400 1/1 cipclicloery 1100a 01/27/2008 Em CA IV B2 USA400 1/1 cipcliery
C(5) 1214a 06/26/2009 7 HA IV C1 USA800 5/5 –
1318a 08/16/2008 Em HA IV C2 USA800 5/5 cip
1324a 08/08/2008 Em HA IV C3 USA800 5/5 cip
1328a 12/23/2008 Em HA IV C4 USA800 5/5 cipcliery
1326a 12/25/2008 9 HA IV C4 USA800 5/5 –
D(1) 1314a 11/08/2008 7 HA IV D ND 484/30 cipcliery
E(1) 1092a 02/22/2008 9 HA III E ND 889/5 cipcloerygensuttec
G(1) 1212a 06/02/2009 ICU HA II G ND 3050/45 cipcliery
H(1) 1219a 06/06/2009 8 HA II H ND 221/221 cipcliery
ICU,intensivecareunit;Em,emergency;ND,notdetermined;HA,hospitalacquired;CA,communityacquired;SCCmec,Staphylococcal cas-settechromosomemec;PFGE,pulsedfieldgelelectrophoresis;ST,sequencetype;CC,clonalcomplex;cip,ciprofloxacin;cli,clindamycin;ery, erythromycin;mup,mupirocin;tec,teicoplanin;clo,chloramphenicol;rif,rifampin;gen,gentamicin;sut,sulfamethoxazole/trimethoprim.
–MDR)wasverifiedin59.3%(19/32),whileamongtheMRSA isolatesfromH2,MDRwasfoundinonly23%(3/13)(p=0.05). Moreover,97% ofthe MRSA isolates from H1 were related toonlytwodisseminatedlineages,USA100/ST5/CC5/SCCmecII (69%) and USA400/ST1/CC1/SCCmecIV (28%), all of them causing hospital-acquired BSI. Furthermore, 94% (15/16) of mupirocin-resistant isolates were found at H1 and it was associated to the USA100 lineage. Two USA100 isolates
(1238a and 1240a) showed high levels of mupirocin resis-tance (MIC>1024g/mL)(datanotshown). Inthis hospital, theprevalentUSA100/ST5/SCCmecIIlineagewasfoundwidely disseminated.AtH2,62%ofMRSAisolatescarriedtheSCCmec IVandwererelatedtoUSA800(38%)orUSA400(23%)lineages. Besides,thepolyclonalpresenceofsporadiclineages(STs484, 889,3050,and221)wasidentifiedinthishospital,theST3050 beingdescribedforthefirsttimeinthisstudy.
Inourstudy,139S. aureusisolatesfrom BSIobtainedat
two different public hospitals in Rio de Janeiro city were
characterized regarding their antimicrobial resistance and
clonalprofile.Weverifiedthatalmost70%oftheBSIisolates
fromthemilitarypublichospital(H1)carriedtheSCCmecIIand
wererelatedtotheUSA100lineage.Allbutoneisolatewere
assignedasUSA400lineage.Thislineageappearstohave
sur-vivalandgrowth advantagesinceithasremainedforyears
asamajorhospital-associatedlineageinUSAandJapan1,12
showingthegoodadaptabilityofsuchclone,evenindifferent
geographicareas.
AtH2, areferenceteaching publichospital,apolyclonal
profile was observed for the MRSA isolates. Interestingly,
wepreviouslyfoundasimilarhigherclonaldiversityamong
MRSAisolatesataprivatehospital.3Thesefindingsmaybe
areflectionoftheoccurrenceoffeweroutbreaksdueto
ade-quateinfectioncontrolmeasuresatthisparticularinstitution,
asfoundinthisteachingpublichospital.Padovezeetal.6
con-ductedacross-sectionalstudyevaluatingacollectionof153
hospitalsfrom fivedifferent Brazilianregions. Theauthors
showedthataminimalstructureisnecessaryforaneffective
preventionofhospitalinfections,speciallythepresenceofan
activeHAIPCC,aswellassterilizationservices,handhygiene
resources,andamicrobiologylaboratory.
Cabocloetal.3comparedS.aureusisolatesfromtwohealth
institutionsinRiodeJaneirobetween2004and2007.Oneof
theseinstitutionswasthesamemilitaryhospital(H1)ofthe
current study.The authors showed adissemination ofthe
USA100, USA400,USA800 andBEClineages atthis military
institution.Moreover,around60%oftheisolateswerefrom
theBEClineage,showingthatatthetimethislineagewasstill
highlypresent.Simultaneously,similarresultswerefoundina
studyconductedataprivatetertiarycarehospitalinSãoPaulo
where40%(13/33)ofMRSAisolatesbelongedtoBECand21%
wererelatedtotheUSA100lineage.13AtH2,Cavalcanteetal.14
showedthattheBEClineagewasresponsibleforaround30%of
allMRSAisolates,between2005and2006.Inthepresentstudy,
carriedoutbetween2008and2009,completeabsenceofthe
BEClineagewasverifiedinbothpublicinstitutionsevaluated,
showingthatcertainglobalMRSAlineagesarereplacingBEC.
Caiaffa-Filhoetal.5recentlyevaluatedacollectionof50
con-secutiveMRSABSIisolatesinaSãoPaulotertiarycareteaching
hospital,betweenOctoberandDecember2010,andfoundthat
asinglePFGEclonerelatedtotheUSA100lineagewas
dissem-inated,almostreplacingtheBECinthatinstitutionduringthe
studyperiod.Thisfindinghighlightsapossiblechangeinthe
epidemiologicalprofileofMRSAinBrazilianhospitals.
MRSAisolatesweremorefrequentlyfoundatH1thanin
theteachinghospital(H2)beingassociatedtoaMDRprofile
and mupirocin resistance.In Brazil, despitethe legislation
mandatingtheimplementationofHAIPCCinthehealth
sys-tem,the lackofqualified professionals,thegrowing health
costs, and limited availability offinancial resources are of
great impact in the infection control.6 Therefore, the
dif-ferencesregardingresistanceratesobservedbetweenMRSA
isolatesfrom the H1 and H2, as well asthe prevalenceof
specificSCCmectypes, maybeareflectionofthe policyfor
controland preventionofinfections and use of
antimicro-bialsinthehospitalsevaluated.Interestingly,theprevalent
USA100clonepresentingMDRprofileisolatedfrom H1had
alreadybeendescribedasaMRSA-daptomycin-resistant
iso-late with vancomycin MIC of 4g/mL, also causing BSI,15
confirming the abilityof this lineage to acquireresistance
determinants.Moreover,thislineagewasalsoassociatedwith
mupirocin resistance, a drug used for decolonizing MRSA
nasalcarriage.2Althoughonlytwoisolateshaveshowedhigh
levelsofmupirocinresistance(MIC>1024g/mL),both
high-andlow-levelresistancehavebeenassociatedwithS.aureus
decolonization failure.2 As showed in a study conducted
in China,2 USA100/ST5 isolates associated with mupirocin
resistanceleadtopossibleoutbreaks. Thedisseminationof
mupirocin-resistantMRSAisolatesamongH1patientsinour
studyalsohighlightstheimportanceofthejudicioususeof
mupirocinamongthehospitalizedpatients.
MRSA, as well asMSSA isolates, havebeen reported as
importantcausesofnosocomialinfections,suchasBSI.1The
present study showedthat S. aureusisolates from the CCs
1 and 5, regardless their methicillin-resistancestatus, had
similar clonality at both hospitals. According to Diep and
Otto,16theemergenceoftheMRSAlineagesaroundtheworld
mayberelatedtothesuccessfulconversionofcertainMSSA
isolatesintoMRSAisolatesbytheacquisitionofSCCmec.The
presence ofMSSAand MRSA isolatespresenting the same
CCsand/orSTshavealreadybeenobservedinRiodeJaneiro
hospitals,4indicatingtheabilityofcertainlineagestoacquire
themeccassettethusprovidinganadvantagetotheir
spread-inginhealthinstitutions.
In conclusion, although both institutions evaluated in
the present study are public hospitals, the military
hospi-tal showed dissemination ofthe USA100/ST5/CC5/SCCmecII
lineage associated to multidrug resistance, including to
mupirocin.Ontheotherhand,theteachinghospitalpresented
polyclonalandnon-multidrugresistantMRSAisolates.These
differencesmayreflectthepolicyofcontrolandprevention
ofinfectionsand/oruseofantimicrobialsemployedineach
hospital evaluated. Moreover,complete substitution of the
BEC/ST239/SCCmecIIIbyotherlineageswasfoundinboth
hos-pitals,highlightingachangeintheepidemiologicalprofileof
MRSAinBrazilianhospitals.
Ethics
statement
ThepresentstudywasapprovedbytheResearchEthics
Com-mitteeunderNo.159/07.
Conflicts
of
interest
Theauthorsdeclarenoconflictsofinterest.
Acknowledgments
Thisstudy wassupportedbygrantsfrom:Fundac¸ãoCarlos
ChagasFilhodeAmparoàPesquisadoEstadodoRiodeJaneiro
(FAPERJ),ConselhoNacionaldeDesenvolvimentoCientíficoe
Tecnológico(CNPq),Coordenac¸ãodeAperfeic¸oamentoPessoal
deNívelSuperior(CAPES),Fundac¸ãoUniversitáriaJosé
We acknowledge the contribution of PhD Rosana
Bar-retoRochaFerreira(InstitutodeMicrobiologiaPaulodeGóes,
UniversidadeFederaldoRiodeJaneiro,RiodeJaneiro)for
pro-vidinglanguagehelpandofthestudentJulianaCuritybade
MelloCamposforthehelpinsomeexperiments.
r
e
f
e
r
e
n
c
e
s
1. RheeY,AroutchevaA,HotaB,etal.Evolvingepidemiologyof
Staphylococcusaureusbacteremia.InfectControlHosp
Epidemiol.2015;36:1417–22.
2. LiuQ,HanL,LiB,etal.VirulencecharacteristicandMLST-agr
geneticbackgroundofhigh-levelmupirocin-resistant,MRSA
isolatesfromShanghaiandWenzhou,China.PLoSONE.
2012;7:e37005.
3. CabocloRM,CavalcanteFS,IorioNL,etal.
Methicillin-resistantStaphylococcusaureusinRiodeJaneiro
hospitals:disseminationoftheUSA400/ST1andUSA800/ST5
SCCmectypeIVandUSA100/ST5SCCmectypeIIlineagesina
publicinstitutionandpolyclonalpresenceinaprivateone.
AmJInfectControl.2013;41:e21–6.
4. SchuenckRP,CavalcanteFS,EmeryE,etal.Staphylococcus
aureusisolatesbelongingtodifferentmultilocussequence
typespresentspecificvirulencegeneprofiles.FEMSImmunol
MedMicrobiol.2012;65:501–4.
5. Caiaffa-FilhoHH,TrindadePA,daCunhaGP,etal.
Methicillin-resistantStaphylococcusaureuscarryingSCCmec
typeIIwasmorefrequentthantheBrazilianendemicclone
asacauseofnosocomialbacteremia.DiagnMicrobiolInfect
Dis.2013;76:518–20.
6. PadovezeMC,FortalezaCM,KifferC,etal.Structurefor
preventionofhealthcare-associatedinfectionsinBrazilian
hospitals:acountrywidestudy.AmJInfectControl.
2016;44:74–9.
7. ClinicalandLaboratoryStandardsInstitute–CLSI.
Performancestandardsforantimicrobialdisksusceptibility
testing.Approvedstandards:M100-S16.Wayne,Pennsylvania,
USA;2015.
8.Milheiric¸oC,OliveiraDC,DeLencastreH.Updatetothe
multiplexPCRstrategyforassignmentformecelementin
Staphylococcusaureus.AntimicrobAgentsChemother. 2007;51:3374–7.
9.VivoniAM,DiepBA,De-Gouveia-MagalhãesAC,etal.Clonal
compositionofStaphylococccusaureusisolatesataBrazilian
universityhospital:identificationofinternationalcirculating
lineages.JClinMicrobiol.2006;44:1686–91.
10.CockfieldJD,PathakS,EdgeworthJD,etal.Rapid
determinationofhospital-acquiredmethicillin-resistant
Staphylococcusaureuslineages.JMedMicrobiol.2007;56: 614–9.
11.EnrightMC,DayNPJ,DaviesCE,etal.Multilocussequence
typingforcharacterizationofmethicillin-resistantand
methicillin-susceptibleclonesofStaphylococcusaureus.JClin
Microbiol.2000;38:1008–15.
12.NakaminamiH,NoguchiN,ItoA,etal.Characterizationof
methicillin-resistantStaphylococcusaureusisolatedfrom
tertiarycarehospitalsinTokyo,Japan.JInfectChemother.
2014;20:512–5.
13.MartinoMDV,CorreaL,PignatariACC,etal.Isolatesof
methicillin-resistantStaphylococcusaureus(MRSA)not
belongingtotheBrazilianepidemicclone.SafHealth.
2015;1:9.
14.CavalcanteFS,SchuenckRP,FerreiraDC,etal.
Methicillin-resistantStaphylococcusaureus:spreadofspecific
lineagesamongpatientsindifferentwardsataBrazilian
teachinghospital.JHospInfect.2014;86:151–4.
15.CavalcanteFS,FerreiraDC,ChamonRC,etal.Daptomycin
andmethicillin-resistantStaphylococcusaureusisolatedfroma
catheter-relatedbloodstreaminfection:acasereport.BMC
ResNotes.2014;25:759.
16.DiepBA,OttoM.Theroleofvirulencedeterminantsin
community-associatedMRSApathogenesis.TrendsMicrobiol.